HIV drug called Intelence (etravirine)
March 2008
You'll see a new HIV drug called Intelence (etravirine).
It's the first non-nucleoside reverse transcriptase inhibitor (NNRTI) in 10 years...joining Sustiva (efavirenz), Viramune (nevirapine), and Rescriptor (delavirdine).
Intelence is for patients resistant to other HIV meds...and will be used with other antiretrovirals.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote